A treatment-resistant, severe type of asthma successfully modeled in mice
A better understanding of inflammation and lung immunity over the past two decades has led to new, innovative treatments for asthma, including biologic therapies.
This is especially true for a subtype known as eosinophilic asthma—asthma that’s related to the recruitment and overactivation of white blood cells in the lungs called eosinophils.
However, a different type of asthma called neutrophilic asthma has fewer treatment options and doesn’t respond as well to first line asthma therapy.
As a result, people with this type of asthma, which ...










